Victor Y.

Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.

Codex FX is the stablecoin-native FX platform for moving money across borders. The platform enables businesses to convert, receive, and pay with fiat and stablecoins at institutional rates, 24/7/365, making global payments faster and more efficient. Founded in 2024, the company is backed by investors including Dragonfly, Coinbase Ventures, Circle Ventures, Wintermute, and Cumberland. Anything to anything.

Zensai, the leading Human Success Platform, seamlessly integrates into Microsoft 365 and Teams and is powered by AI. Our mission? To unlock human potential worldwide. With a global presence spanning 60+ countries and millions of users, Zensai revolutionizes employee development, engagement, and performance management. As a Microsoft Preferred Solution, we redefine success metrics, offering a best-practice framework and solution for learning, engagement, and performance that is delivered in the Microsoft 365 environment. Driven by AI, designed for productivity, and aligned with your unique workflow.

Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.

Blue Cloud Ventures, (BCV), is a software-focused growth equity venture capital firm based in New York City. The fund targets investments in leading SaaS, infrastructure and open source software companies. BCV offers entrepreneurs an alternative to raising a traditional growth round by being flexible on amount invested, ownership requirements, board representation and exit horizon. BCV supports entrepreneurs in raising the optimal growth round and enables early stage investors to double down on their most promising companies.